Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0756
D

Failure to Act on Pharmacist's Recommendation for Digoxin Level Monitoring

Minneapolis, Minnesota Survey Completed on 04-17-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that consulting pharmacist recommendations for laboratory monitoring of a resident receiving digoxin were acted upon and addressed in a timely manner. A resident with moderate cognitive impairment, heart failure, and schizophrenia was prescribed digoxin for chronic diastolic heart failure, with daily administration documented and pulse checks recorded. The resident's care plan included general interventions for cardiac complications but did not specify how or when digoxin levels should be monitored. The consulting pharmacist identified the absence of a digoxin level in the medical record and recommended obtaining a digoxin level and basic metabolic panel. Although the physician indicated acceptance of the recommendations, there was no documentation that the digoxin level was obtained or that a rationale was provided for not doing so. Subsequent medication regimen reviews by the consulting pharmacist did not identify further irregularities, but the medical record continued to lack evidence of digoxin level monitoring. Interviews with the DON and consulting pharmacist confirmed that the recommendation for laboratory monitoring was not addressed, and there was no follow-up or documentation explaining the omission. The facility was unable to provide a policy on consulting pharmacist recommendations, and the process for ensuring such recommendations were implemented was not clearly documented or followed.

An unhandled error has occurred. Reload 🗙